The Benefits and Side Effects of Bevacizumab for the Treatment of Recurrent Ovarian Cancer
Journal:
Current Drug Targets
Volume:
18
Page:
1125-1131
Author(s):
Wenwen Zhang, Zhaojun Shen, Hui Luo, Xiaoli Hu, Lihong Zheng and Xueqiong Zhu*
Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions
Journal:
Current Medicinal Chemistry
Volume:
24
Page:
1586-1606
Author(s):
Spyridon P. Basourakos, Likun Li, Ana M. Aparicio, Paul G. Corn, Jeri Kim and Timothy C. Thompson*
Liposomal Drug Delivery System for Cancer Therapy: Advancement and Patents
Journal:
Recent Patents on Drug Delivery & Formulation
Volume:
10
Page:
177-183
Author(s):
Sheetal Jha, Pramod K. Sharma and Rishabha Malviya
Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
755-764
Author(s):
Senthamil R. Selvan, John P. Dowling, William K. Kelly and Jianqing Lin
Overcoming Chemotherapy Resistance in High Grade Serous Ovarian Cancer
Journal:
Current Cancer Therapy Reviews
Volume:
12
Page:
23-36
Author(s):
Raghav Sundar, David Tan, Lim S. Lei and Whay-Kuang Chia
Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
4717-4728
Author(s):
Bradley J. Monk, Thomas J. Herzog and Krishnansu S. Tewari
P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update
Journal:
Current Drug Metabolism
Volume:
17
Page:
806-826
Author(s):
Xiaobo Yang and Kexin Liu
Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
816-831
Author(s):
Tapan Kumar Giri, Ayan Giri, Tapan Kumar Barman and Subhasis Maity
Treatment of High-Grade Pelvic-Type Serous Carcinomas (Ovary, Fallopian Tube and Peritoneum): Current Therapeutic Paradigms, Prospects, and Challenges
Journal:
Current Cancer Therapy Reviews
Volume:
11
Page:
300-313
Author(s):
Mary Chu, D. Stave Kohtz, Estrelania Williams, Tamara Kalir and David Fishman
The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma
Journal:
Current Drug Targets
Volume:
17
Page:
196-205
Author(s):
Maria T. Bourlon and Thomas W. Flaig